Targeted Immunotherapy IS the Next Big Thing in Biotechnology
There was human insulin that "would never replace porcine extracted insulin" as primary insulin for the treatment of type I diabetes, then tPA that "was no better than streptokinase" at thwarting heart attacks, followed by a whole slew of monoclonal antibodies. Tomorrow's successful biotechnology products are going to be targeted immunotherapies with companion diagnostics to identify specifically the patients that will benefit from treatment. Do you know the only independent company with a platform focused on the development of just such new life-saving medicines? Exactly. We are going higher gentlement because everyone should want to invest in a compnay at the genesis stage of becoming a leader in the next big thing in biotechnology? Buy more Celldex.